Vitamin K epoxide reductase — Drug Target

All drugs that target Vitamin K epoxide reductase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Vitamin K antagonist

Phase 3 pipeline (1)

• warfarine - low molecular heparin · University Hospital, Limoges · Vitamin K antagonist · Cardiovascular
  Warfarin inhibits the synthesis of vitamin K-dependent clotting factors in the liver, preventing blood clot formation.